Guideline
Management of Infants at Risk for Group B Streptococcal Disease.
- Early-onset sepsis
- Infection
- Late-onset sepsis
- Medical
- Nursing
This guideline is from 2019, more than five years ago. Check whether a newer version exists and which version your unit follows.
Summary
This AAP clinical report, endorsed by ACOG, updates neonatal clinicians on the epidemiology of group B streptococcal disease, the leading cause of neonatal early-onset sepsis and an important cause of late-onset sepsis. It reaffirms universal antenatal microbiological screening for maternal GBS colonisation to guide intrapartum antibiotic prophylaxis. It sets out current recommendations for evaluating newborn infants at risk of GBS disease and for treating those with confirmed infection. It also notes that no effective strategy currently exists to prevent late-onset GBS disease.
Summary written for NICUlearn. Always read the original.
- Licence:
- Summary and link only
Guidelines are shown for education. Follow your unit's own guidance and senior advice.